Hou-teh Lu, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 146 E Hospital Dr, Ste 105, Angleton, TX 77515 Phone: 979-849-2381 Fax: 979-849-0665 |
Elizabeth A Gordon, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 146 E Hospital Dr Ste 106, Angleton, TX 77515 Phone: 979-864-3034 |
Edward L Chang, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 146 E Hospital Dr Ste 105, Angleton, TX 77515 Phone: 979-849-2381 Fax: 979-849-0665 |
News Archive
Clearstone Central Laboratories, a leading provider of central laboratory services for late-stage clinical trials, announced today a global collaboration with Laboratory Corporation of America® Holdings through its Esoterix Clinical Trials Services division, providing clients with seamless access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States.
Millennium: The Takeda Oncology Company today reported on data from oral presentations of VELCADE® (bortezomib) for Injection based therapy in multiple myeloma presented at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). These data highlight VELCADE based therapy in both transplant and non-transplant eligible previously untreated multiple myeloma patients, as well as VELCADE used as induction and/or maintenance therapy.
Treatment for heart failure should take into consideration a patient's social determinants of health - their overall living environment, socio-economic status, as well as the needs of unpaid family caregivers, according to two new scientific statements from the American Heart Association, published simultaneously today in the Association's flagship journal Circulation.
Researchers with the National Cancer Institute (NCI) have found that the prevalence of tamoxifen use for the prevention of breast cancer among women without a personal history of breast cancer is very low.
Nearly half of all Americans used at least one prescription drug per month in 2008, according to a study by the Centers for Disease Control and Prevention, Bloomberg reports. That's a 10 percent increase over the preceding decade. Over that time, yearly spending by Americans on drugs doubled to $234 billion. "The two biggest-sellers last year were Pfizer Inc.'s Lipitor for high cholesterol and Bristol-Myers Squibb Co.'s clot-buster, Plavix.
› Verified 9 days ago